With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Genetically Modified, Cord Blood Derived Natural Killer Cell Therapy for High Grade Pediatric Brain Tumors||Children's Research Institute / Conrad Russell Cruz, MD, PhD||'A' Award Grants||2015||District of Columbia|
|Functional Dissection of Oncogenic Enhancers in T-ALL||Columbia University / Daniel Herranz, PhD||Young Investigator Grants||2015||New York|
|Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD||Reach Grants||2015||Massachusetts|
|Elucidating Mechanisms Driving Renal Medullary Carcinomas to Deliver a Rational Approach to Cancer Directed Therapy||Dana-Farber Cancer Institute / Andrew Hong, MD||Young Investigator Grants||2015||Massachusetts|
|Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD||Innovation Grants||2015||Massachusetts|
|The Role of DEF and SSU Processome in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Ting Tao, PhD||Young Investigator Grants||2015||Massachusetts|
|Novel Nanoscale Phosphoproteomic Discovery of Therapeutic Targets in AML Stem Cells||Dana-Farber Cancer Institute / Leo Wang, MD, PhD||Young Investigator Grants||2015||Massachusetts|
|A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor||Dana-Farber Cancer Institute / Shuning He, PhD||Young Investigator Grants||2015||Massachusetts|
|The Role of PARP3 in the Formation of Chromosomal Translocations||Dana-Farber Cancer Institute / Tovah Day, PhD||Young Investigator Grants||2015||Massachusetts|